Multiplex Bead Assay for Integrated Serological Surveillance of Communicable Diseases in the Region of the Americas. Report of the third regional meeting (Cuernavaca, 4-5 March 2020)
Gov't Doc #
MetadataShow full item record
Other Language Versions
In 2016, the Pan American Health Organization, in partnership with the U.S. Centers for Disease Control and Prevention, began a collaborative effort with delegates from Brazil, Mexico, and Paraguay aimed at transferring technical capacity for integrated serological surveillance of population immunity and transmission of multiple infectious diseases, using the multiplex bead assay (MBA) platform. MBA makes it possible to analyze the antibodies of up to 96 antigens of various pathogens in a single dried-spot blood sample. Serological surveillance is being increasingly used for its ability to generate information that helps characterize disease transmission and monitor the impact of interventions such as vaccination, and to identify susceptible populations. This initiative has served as a learning process based on interprogrammatic work to develop integrated serological surveillance of various diseases and events that are often addressed separately from a programmatic standpoint, but which in reality overlap in the same population groups and geographical areas. This document presents the results of the third regional meeting, held in the city of Cuernavaca, Mexico, on 4-5 March 2020, and attended by delegates from the participating countries, partners, and stakeholders. This publication highlights the lessons learned during the first stage of capacity transfer, and discusses opportunities and next steps to expand integrated serological surveillance in the Region of the Americas as a tool for strengthening surveillance of communicable diseases.
Vigilancia serológica integrada de las enfermedades transmisibles mediante el ensayo de perlas múltiples en la Región de las Américas. Informe de la tercera reunión regional (Cuernavaca, 4 y 5 de marzo del 2020)
Multiplex Bead Assay for Integrated Serological Surveillance of Communicable Diseases in the Region of the Americas. Report of the third regional meeting (Cuernavaca, 4-5 March 2020). Washington, D.C.: Pan American Health Organization; 2020. License: CC BY-NC-SA 3.0 IGO.
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
Pan American Health Organization; Communication (CMU) (Washington, D.C., PAHO, 2020-06-26)Introduction: The outbreak of coronavirus 2019 disease (COVID-19) in Hubei, China, and the introduction of the virus into the Region of the Americas highlight the urgent need for clear, concise and consistent communication. ...
Epidemic of Chronic Kidney Disease in Agricultural Communities in Central America. Case definitions, methodological basis and approaches for public health surveillance Pan American Health Organization (Washington, D.C, PAHO, 2017-06)In the last four decades, increasing numbers of young people, in clusters of vulnerable farming communities in several Central American countries, have developed a severe form of kidney failure of uncertain etiology ...
Health statistics from the Americas : Mortality : Trends from 1960 and latest data by cause, age, and sex : Morbidity : Annual series of reported cases of selected communicable diseases Pan American Health Organization (1992)This publication primarily presents estimated cause-group specific death rates for 24 countries, by age group and sex, for each five-year period between 1960-1964 and 1985-1989; rates by age group and sex, but not by cause ...